Economics at your fingertips  


1997 - 2023

Current editor(s): Timothy Wrightson and Christopher I. Carswell

From Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

Access Statistics for this journal.
Track citations for all items by RSS feed
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 41, issue 6, 2023

The Value of Health in a Cost-Effectiveness Analysis: Theory Versus Practice pp. 607-617 Downloads
Bram Wouterse, Pieter Baal, Matthijs Versteegh and Werner Brouwer
Comprehensive Review of Methods to Assess Uncertainty in Health Economic Evaluations pp. 619-632 Downloads
Thomas Michael Otten, Sabine E. Grimm, Bram Ramaekers and Manuela A. Joore
Critical Appraisal of Decision Models Used for the Economic Evaluation of Bladder Cancer Screening and Diagnosis: A Systematic Review pp. 633-650 Downloads
Olena Mandrik, Anne I. Hahn, James W. F. Catto, Ann G. Zauber, Marcus Cumberbatch and James Chilcott
Cost Effectiveness of Pharmacological and Non-pharmacological Treatments for Depression in Low- and Middle-Income Countries: A Systematic Literature Review pp. 651-673 Downloads
Yared Belete Belay, Lidia Engel, Yong Yi Lee, Ngoc Le and Cathrine Mihalopoulos
Capturing the Impact of Constraints on the Cost-Effectiveness of Cell and Gene Therapies: A Systematic Review pp. 675-692 Downloads
Sean P. Gavan, Stuart J. Wright, Fiona Thistlethwaite and Katherine Payne
Infectious Disease Modelling of HIV Prevention Interventions: A Systematic Review and Narrative Synthesis of Compartmental Models pp. 693-707 Downloads
Rebecca Giddings, Pitchaya Indravudh, Graham F. Medley, Fiammetta Bozzani, Mitzy Gafos, Shelly Malhotra, Fern Terris-Prestholt, Sergio Torres-Rueda and Matthew Quaife
Cost Effectiveness of CDK4/6 Inhibitors in the First-Line Treatment of HR+/HER2− Metastatic Breast Cancer in Postmenopausal Women in the USA pp. 709-718 Downloads
Prajakta P. Masurkar, Haluk Damgacioglu, Ashish A. Deshmukh and Meghana V. Trivedi
Projecting the Health and Economic Burden of Cardiovascular Disease Among People with Type 2 Diabetes, 2022–2031 pp. 719-732 Downloads
Dina Abushanab, Clara Marquina, Jedidiah I. Morton, Daoud Al-Badriyeh, Melanie Lloyd, Dianna J. Magliano, Danny Liew and Zanfina Ademi

Volume 41, issue 5, 2023

Costs and Cost-Effectiveness of Biomedical, Non-Surgical HIV Prevention Interventions: A Systematic Literature Review pp. 467-480 Downloads
Fiammetta M. Bozzani, Fern Terris-Prestholt, Matthew Quaife, Mitzy Gafos, Pitchaya P. Indravudh, Rebecca Giddings, Graham F. Medley, Shelly Malhotra and Sergio Torres-Rueda
Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella pp. 481-497 Downloads
Kris Doggen, Albert Jan van Hoek and Jeroen Luyten
Economic Analyses of Obsessive-Compulsive Disorder Interventions: A Systematic Review pp. 499-527 Downloads
Emily R. Strouphauer, Olivia J. Morris, Keaton J. Soileau, Andrew D. Wiese, Troy Quast, Wayne K. Goodman, Sameer A. Sheth, Katharine D. Wojcik, Andrew G. Guzick and Eric A. Storch
HTA Barriers for Conditional Approval Drugs pp. 529-545 Downloads
Mackenzie Mills
Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UK pp. 547-559 Downloads
Junwen Zhou, Runguo Wu, Claire Williams, Jonathan Emberson, Christina Reith, Anthony Keech, John Robson, Kenneth Wilkinson, Jane Armitage, Alastair Gray, John Simes, Colin Baigent and Borislava Mihaylova
How to Predict Drug Expenditure: A Markov Model Approach with Risk Classes pp. 561-572 Downloads
Valeska Hofbauer-Milan, Stefan Fetzer and Christian Hagist
The Cost of Uncontrolled Blood Pressure in Australian General Practice: A Modelling Study Using Electronic Health Records (MedicineInsight) pp. 573-587 Downloads
Jacqueline Roseleur, David A. Gonzalez-Chica, Gillian Harvey, Nigel P. Stocks and Jonathan Karnon
Cost-Effectiveness Analysis of Tofacitinib Compared with Biologics in Biologic-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan pp. 589-604 Downloads
Taku Kobayashi, Masato Hoshi, Akira Yuasa, Shoko Arai, Mitsunobu Ikeda, Hiroyuki Matsuda, Seok-Won Kim and Toshifumi Hibi
Correction to: Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US pp. 605-605 Downloads
Hardik Goswami, Adnan Alsumali, Yiling Jiang, Matthias Schindler, Elizabeth R. Duke, Joshua Cohen, Andrew Briggs and Amy Puenpatom

Volume 41, issue 4, 2023

Modelling the Cost-Effectiveness of Diagnostic Tests pp. 339-351 Downloads
Tristan Snowsill
Pralsetinib for RET Fusion-Positive Advanced Non-small-Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal pp. 353-361 Downloads
Mohamed N. M. T. Al Khayat, Nigel Armstrong, Jeremy Howick, Susan O’Meara, Pawel Posadzki, Steve Ryder, Charlotte Ahmadu, Stefan R. A. Konings, Maarten J. Postma, Steven Duffy, Robert F. Wolff and Antoinette D. I. Asselt
Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review pp. 363-391 Downloads
Nannan Li, Charlotte Beaudart, Jane A. Cauley, Steven W. Ing, Nancy E. Lane, Jean-Yves Reginster, Stuart Silverman, Andrea J. Singer and Mickaël Hiligsmann
Correction to: Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review pp. 393-393 Downloads
Nannan Li, Charlotte Beaudart, Jane A. Cauley, Steven W. Ing, Nancy E. Lane, Jean‑Yves Reginster, Stuart Silverman, Andrea J. Singer and Mickaël Hiligsmann
Population-Based Screening Using Low-Dose Chest Computed Tomography: A Systematic Review of Health Economic Evaluations pp. 395-411 Downloads
Carina M. Behr, Martijn J. Oude Wolcherink, Maarten J. IJzerman, Rozemarijn Vliegenthart and Hendrik Koffijberg
Cost Effectiveness of Implementing a Universal Birth Hepatitis B Vaccination Program in Ontario pp. 413-425 Downloads
John J. Kim, Wasem Alsabbagh and William W. L. Wong
The Use of a Discrete Choice Experiment Including Both Duration and Dead for the Development of an EQ-5D-5L Value Set for Australia pp. 427-438 Downloads
Richard Norman, Brendan Mulhern, Emily Lancsar, Paula Lorgelly, Julie Ratcliffe, Deborah Street and Rosalie Viney
Identifying Attributes for a Value Assessment Framework in China: A Qualitative Study pp. 439-455 Downloads
Mengmeng Zhang, Yun Bao, Yi Yang, Melissa Kimber, Mitchell Levine and Feng Xie
Cost Effectiveness of Difelikefalin Compared to Standard Care for Treating Chronic Kidney Disease Associated Pruritus (CKD-aP) in People with Kidney Failure Receiving Haemodialysis pp. 457-466 Downloads
Praveen Thokala, Pann Ei Hnynn Si, Monica Hernandez Alava, Alessandro Sasso, Thilo Schaufler, Marco Soro and James Fotheringham

Volume 41, issue 3, 2023

Living Health Technology Assessment: Issues, Challenges and Opportunities pp. 227-237 Downloads
Praveen Thokala, Tushar Srivastava, Robert Smith, Shijie Ren, Melanie D. Whittington, Jamie Elvidge, Ruth Wong and Lesley Uttley
Filgotinib for Treating Moderately to Severely Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal pp. 239-251 Downloads
Antoinette D. I. Asselt, Nigel Armstrong, Merel Kimman, Andrea Peeters, Kevin McDermott, Lisa Stirk, Charlotte Ahmadu, Tim M. Govers, Frank Hoentjen, Manuela A. Joore and Sabine E. Grimm
Impact of Influenza and Influenza-Like Illness on Work Productivity Outcomes: A Systematic Literature Review pp. 253-273 Downloads
Marie-Hélène Blanchet Zumofen, Jeff Frimpter and Svenn Alexander Hansen
Caregiver Burden of Spinal Muscular Atrophy: A Systematic Review pp. 275-293 Downloads
Erik Landfeldt, Sophia Abner, Astrid Pechmann, Thomas Sejersen, Hugh J. McMillan, Hanns Lochmüller and Janbernd Kirschner
Whether and How Disutilities of Adverse Events were Used in the Economic Evaluation of Drug Therapy for Cancer Treatment pp. 295-306 Downloads
Yuqiong Lu, Zhanjing Dai, Feng Chang, Li Wang, Jiafang He, Penghua Shi, Haitao Zhang and Yun Lu
Cost-Effectiveness Analysis of a New Second-Line Treatment Regimen for Advanced Intrahepatic Cholangiocarcinoma: Biomarker-Driven Targeted Therapy of Pemigatinib Versus 5-FU Chemotherapy pp. 307-319 Downloads
Chen-Han Chueh, Yi-Wen Tsai, Zi-Rong Chen, Ming-Neng Shiu, Yu-Wen Wen and Nai-Jung Chiang
Incorporating Dynamic Pricing in Cost-Effectiveness Analysis: Are Known Unknowns Valuable? pp. 321-327 Downloads
R. Brett McQueen, Kelly E. Anderson, Joseph F. Levy and Josh J. Carlson
The Egyptian EQ-5D-5L Extensive Pilot Study: Lessons Learned pp. 329-338 Downloads
Sahar Al Shabasy, Bram Roudijk, Maggie Abbassi, Aureliano Finch, Elly Stolk and Samar Farid

Volume 41, issue 2, 2023

Best Practices: A Collection of Systematic Critical Reviews of Modeling Approaches in Specific Disease Areas pp. 119-121 Downloads
J. Jaime Caro
How is the Societal Perspective Defined in Health Technology Assessment? Guidelines from Around the Globe pp. 123-138 Downloads
Tuba Saygın Avşar, Xiaozhe Yang and Paula Lorgelly
The Societal Cost of Schizophrenia: An Updated Systematic Review of Cost-of-Illness Studies pp. 139-153 Downloads
Claire Lin, Xiaoyu Zhang and Huajie Jin
Psychometric Properties of Generic Preference-Weighted Measures for Children and Adolescents: A Systematic Review pp. 155-174 Downloads
Rachel Lee-Yin Tan, Sonia Zhi Yi Soh, Le Ann Chen, Michael Herdman and Nan Luo
Cost-effectiveness Analysis of Tisagenlecleucel Versus Blinatumomab in Children and Young Adults with Acute Lymphoblastic Leukemia: Partitioned Survival Model to Assess the Impact of an Outcome-Based Payment Arrangement pp. 175-186 Downloads
Amy Gye, Stephen Goodall and Richard Abreu Lourenco
Mapping the Patient-Reported Outcomes Measurement Information System (PROMIS-29) to EQ-5D-5L pp. 187-198 Downloads
Mona Aghdaee, Yuanyuan Gu, Kompal Sinha, Bonny Parkinson, Rajan Sharma and Henry Cutler
Estimating the Relationship Between EQ-5D-5L and EQ-5D-3L: Results from a UK Population Study pp. 199-207 Downloads
Mónica Hernández Alava, Steve Pudney and Allan Wailoo
Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy pp. 209-225 Downloads
Carla Rognoni, Camilla Falivena, Francesco Costa and Patrizio Armeni

Volume 41, issue 1, 2023

Health Economic Evaluation Using Markov Models in R for Microsoft Excel Users: A Tutorial pp. 5-19 Downloads
Nathan Green, Felicity Lamrock, Nichola Naylor, Jack Williams and Andrew Briggs
Extensions of Health Economic Evaluations in R for Microsoft Excel Users: A Tutorial for Incorporating Heterogeneity and Conducting Value of Information Analyses pp. 21-32 Downloads
Nichola R. Naylor, Jack Williams, Nathan Green, Felicity Lamrock and Andrew Briggs
Fenfluramine for Treating Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal pp. 33-42 Downloads
Ben Wijnen, Willem Witlox, Robert Wolff, Debra Fayter, Bram Ramaekers, Thomas Otten, Steve Ryder, Pawel Posadzki, Gill Worthy, Lisa Stirk, Nigel Armstrong, Jos Kleijnen and Manuela Joore
Patient Preferences in Targeted Pharmacotherapy for Cancers: A Systematic Review of Discrete Choice Experiments pp. 43-57 Downloads
Shan Jiang, Ru Ren, Yuanyuan Gu, Varinder Jeet, Ping Liu and Shunping Li
The Costs of Dementia in Europe: An Updated Review and Meta-analysis pp. 59-75 Downloads
Linus Jönsson, Ashley Tate, Oskar Frisell and Anders Wimo
Cost-Utility Analysis of Universal Maternal Pertussis Immunisation in Thailand: A Comparison of Two Model Structures pp. 77-91 Downloads
Siobhan Botwright, Ei Mon Win, Nattiya Kapol, Sirikanlaya Benjawan and Yot Teerawattananon
Health-Related Quality-of-Life Outcomes of Very Preterm or Very Low Birth Weight Adults: Evidence From an Individual Participant Data Meta-Analysis pp. 93-105 Downloads
Corneliu Bolbocean, Sylvia Pal, Stef Buuren, Peter J. Anderson, Peter Bartmann, Nicole Baumann, Jeanie L. Y. Cheong, Brian A. Darlow, Lex W. Doyle, Kari Anne I. Evensen, John Horwood, Marit S. Indredavik, Samantha Johnson, Neil Marlow, Marina Mendonça, Yanyan Ni, Dieter Wolke, Lianne Woodward, Erik Verrips and Stavros Petrou
Role of Economic Evaluations on Pricing of Medicines Reimbursed by the Italian National Health Service pp. 107-117 Downloads
Pierluigi Russo, Matteo Zanuzzi, Angelica Carletto, Annalisa Sammarco, Federica Romano and Andrea Manca
Page updated 2023-05-30